Self-inactivating retroviral vectors with improved RNA processing. 2004

J Kraunus, and D H S Schaumann, and J Meyer, and U Modlich, and B Fehse, and G Brandenburg, and D von Laer, and H Klump, and A Schambach, and J Bohne, and C Baum
Department of Cell & Virus Genetics, Heinrich-Pette-Institute, Hamburg, Germany.

Three RNA features have been identified that elevate retroviral transgene expression: an intron in the 5' untranslated region (5'UTR), the absence of aberrant translational start codons and the presence of the post-transcriptional regulatory element (PRE) of the woodchuck hepatitis virus in the 3'UTR. To include such elements into self-inactivating (SIN) vectors with potentially improved safety, we excised the strong retroviral promoter from the U3 region of the 3' long terminal repeat (LTR) and inserted it either downstream or upstream of the retroviral RNA packaging signal (Psi). The latter concept is new and allows the use of an intron in the 5'UTR, taking advantage of retroviral splice sites surrounding Psi. Three LTR and four SIN vectors were compared to address the impact of RNA elements on titer, splice regulation and transgene expression. Although titers of SIN vectors were about 20-fold lower than those of their LTR counterparts, inclusion of the PRE allowed production of more than 10(6) infectious units per ml without further vector optimizations. In comparison with state-of-the-art LTR vectors, the intron-containing SIN vectors showed greatly improved splicing. With regard to transgene expression, the intron-containing SIN vectors largely matched or even exceeded the LTR counterparts in all cell types investigated (embryonic carcinoma cells, fibroblasts, primary T cells and hematopoietic progenitor cells).

UI MeSH Term Description Entries
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D005818 Genetic Engineering Directed modification of the gene complement of a living organism by such techniques as altering the DNA, substituting genetic material by means of a virus, transplanting whole nuclei, transplanting cell hybrids, etc. Genetic Intervention,Engineering, Genetic,Intervention, Genetic,Genetic Interventions,Interventions, Genetic
D005822 Genetic Vectors DNA molecules capable of autonomous replication within a host cell and into which other DNA sequences can be inserted and thus amplified. Many are derived from PLASMIDS; BACTERIOPHAGES; or VIRUSES. They are used for transporting foreign genes into recipient cells. Genetic vectors possess a functional replicator site and contain GENETIC MARKERS to facilitate their selective recognition. Cloning Vectors,Shuttle Vectors,Vectors, Genetic,Cloning Vector,Genetic Vector,Shuttle Vector,Vector, Cloning,Vector, Genetic,Vector, Shuttle,Vectors, Cloning,Vectors, Shuttle
D006412 Hematopoietic Stem Cells Progenitor cells from which all blood cells derived. They are found primarily in the bone marrow and also in small numbers in the peripheral blood. Colony-Forming Units, Hematopoietic,Progenitor Cells, Hematopoietic,Stem Cells, Hematopoietic,Hematopoietic Progenitor Cells,Cell, Hematopoietic Progenitor,Cell, Hematopoietic Stem,Cells, Hematopoietic Progenitor,Cells, Hematopoietic Stem,Colony Forming Units, Hematopoietic,Colony-Forming Unit, Hematopoietic,Hematopoietic Colony-Forming Unit,Hematopoietic Colony-Forming Units,Hematopoietic Progenitor Cell,Hematopoietic Stem Cell,Progenitor Cell, Hematopoietic,Stem Cell, Hematopoietic,Unit, Hematopoietic Colony-Forming,Units, Hematopoietic Colony-Forming
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012323 RNA Processing, Post-Transcriptional Post-transcriptional biological modification of messenger, transfer, or ribosomal RNAs or their precursors. It includes cleavage, methylation, thiolation, isopentenylation, pseudouridine formation, conformational changes, and association with ribosomal protein. Post-Transcriptional RNA Modification,RNA Processing,Post-Transcriptional RNA Processing,Posttranscriptional RNA Processing,RNA Processing, Post Transcriptional,RNA Processing, Posttranscriptional,Modification, Post-Transcriptional RNA,Modifications, Post-Transcriptional RNA,Post Transcriptional RNA Modification,Post Transcriptional RNA Processing,Post-Transcriptional RNA Modifications,Processing, Posttranscriptional RNA,Processing, RNA,RNA Modification, Post-Transcriptional,RNA Modifications, Post-Transcriptional
D012449 Safety Freedom from exposure to danger and protection from the occurrence or risk of injury or loss. It suggests optimal precautions in the workplace, on the street, in the home, etc., and includes personal safety as well as the safety of property. Safeties
D014162 Transfection The uptake of naked or purified DNA by CELLS, usually meaning the process as it occurs in eukaryotic cells. It is analogous to bacterial transformation (TRANSFORMATION, BACTERIAL) and both are routinely employed in GENE TRANSFER TECHNIQUES. Transfections

Related Publications

J Kraunus, and D H S Schaumann, and J Meyer, and U Modlich, and B Fehse, and G Brandenburg, and D von Laer, and H Klump, and A Schambach, and J Bohne, and C Baum
November 1994, Journal of virology,
J Kraunus, and D H S Schaumann, and J Meyer, and U Modlich, and B Fehse, and G Brandenburg, and D von Laer, and H Klump, and A Schambach, and J Bohne, and C Baum
August 1997, Journal of virology,
J Kraunus, and D H S Schaumann, and J Meyer, and U Modlich, and B Fehse, and G Brandenburg, and D von Laer, and H Klump, and A Schambach, and J Bohne, and C Baum
November 1995, Journal of virology,
J Kraunus, and D H S Schaumann, and J Meyer, and U Modlich, and B Fehse, and G Brandenburg, and D von Laer, and H Klump, and A Schambach, and J Bohne, and C Baum
June 2007, Molecular therapy : the journal of the American Society of Gene Therapy,
J Kraunus, and D H S Schaumann, and J Meyer, and U Modlich, and B Fehse, and G Brandenburg, and D von Laer, and H Klump, and A Schambach, and J Bohne, and C Baum
January 2012, Molecular therapy : the journal of the American Society of Gene Therapy,
J Kraunus, and D H S Schaumann, and J Meyer, and U Modlich, and B Fehse, and G Brandenburg, and D von Laer, and H Klump, and A Schambach, and J Bohne, and C Baum
May 1986, Proceedings of the National Academy of Sciences of the United States of America,
J Kraunus, and D H S Schaumann, and J Meyer, and U Modlich, and B Fehse, and G Brandenburg, and D von Laer, and H Klump, and A Schambach, and J Bohne, and C Baum
November 2006, Gene therapy,
J Kraunus, and D H S Schaumann, and J Meyer, and U Modlich, and B Fehse, and G Brandenburg, and D von Laer, and H Klump, and A Schambach, and J Bohne, and C Baum
January 2009, Journal of biomedicine & biotechnology,
J Kraunus, and D H S Schaumann, and J Meyer, and U Modlich, and B Fehse, and G Brandenburg, and D von Laer, and H Klump, and A Schambach, and J Bohne, and C Baum
January 2013, PeerJ,
J Kraunus, and D H S Schaumann, and J Meyer, and U Modlich, and B Fehse, and G Brandenburg, and D von Laer, and H Klump, and A Schambach, and J Bohne, and C Baum
May 2022, Viruses,
Copied contents to your clipboard!